Gara Jalqabaatti › Tumora Oljoo › North Carolina
Qorannoo klinikaalii Tumora Oljoo North Carolina keessatti
Qorannoo 20 Tumora Oljoo f North Carolina keessatti hirmaatuu jiru.
Magaalota North Carolina keessatti
Takkalaa qorannoo (Ingiliffa)
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Duke University School of Medicine, Durham
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT05786924A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0100, Durham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07492680A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Wake Forest University at Clemmons, Clemmons
- Southeastern Medical Oncology Center-Clinton, Clinton
- Southeastern Medical Oncology Center-Goldsboro, Goldsboro
- fi 4 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT04511013A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Duke Cancer Institute, Durham
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06253871A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Duke University, Durham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07428616Targeted Pediatric High-Grade Glioma Therapy
- Duke University Health System, Durham
Namoota walitti qabaa jiraQorannoo ilaalaa
12 Months – 39 Years · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Duke University Health System, Durham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 hanga 39 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06161974ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
- Duke University Medical Center, Durham
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05609994Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
- Atrium Health Wake Forest Baptist, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT05317858MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT04073966B6 Administration for Levetiracetam-Associated Neurobehavioral Changes and Epilepsy
- Duke University Medical Center, Durham
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT07271966Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Vidant Heath - ECU Medical Center, Greenville
- Atlantic Brain & Spine, Wilmington
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT04427384Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ado-2026 · NCT05692635REMASTer: REcurrent Brain Metastases After SRS Trial
- Wake Forest Baptist Medical Center, Winston-Salem
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Wax-2026 · NCT05124912Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- Cone Health Cancer Center, Greensboro
- Wake Forest University Health Sciences, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Wax-2026 · NCT03550391Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Duke University Health System, Durham
Namoota walitti qabaa jiraSadarkaa 2
12 Months – 39 Years · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT05843253Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
- Lineberger Comprehensive Cancer Center, Chapel Hill
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Elb-2026 · NCT05366179Key Longitudinal Associations With Risk and Glioblastoma Outcomes
- Duke University, Durham
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT06625684Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
- Duke Cancer Center, Durham
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Sad-2025 · NCT05480644APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- University of North Carolina, Chapel Hill
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Wax-2025 · NCT03175224Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.